Published in Clin Cardiol on February 01, 2008
Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studies. Europace (2013) 1.53
Costs of major intracranial, gastrointestinal and other bleeding events in patients with atrial fibrillation - a nationwide cohort study. BMC Health Serv Res (2017) 1.38
An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality. Europace (2010) 1.08
Electrophysiological remodeling in heart failure. J Mol Cell Cardiol (2010) 1.05
Atrial fibrillation and heart failure parallels: lessons for atrial fibrillation prevention. Crit Pathw Cardiol (2011) 0.92
NOX4-Dependent Hydrogen Peroxide Overproduction in Human Atrial Fibrillation and HL-1 Atrial Cells: Relationship to Hypertension. Front Physiol (2012) 0.89
Current ablation strategies for persistent and long-standing persistent atrial fibrillation. Cardiol Res Pract (2011) 0.88
Fibrosis in Atrial Fibrillation - Role of Reactive Species and MPO. Front Physiol (2012) 0.87
Statin therapy may influence the incidence of postoperative atrial fibrillation: what is the evidence? Tex Heart Inst J (2009) 0.85
Stroke prevention with oral anticoagulation in older people with atrial fibrillation - a pragmatic approach. Aging Dis (2012) 0.82
Advances in atrial fibrillation ablation. J Invasive Cardiol (2009) 0.80
Management of stroke prevention in canadian patients with atrial fibrillation at moderate to high risk of stroke. Can J Hosp Pharm (2013) 0.78
Association Between Usual Vitamin K Intake and Anticoagulation in Patients Under Warfarin Therapy. Clin Nutr Res (2015) 0.75
Modulation of drug block of the cardiac potassium channel KCNA5 by the drug transporters OCTN1 and MDR1. Br J Pharmacol (2010) 0.75
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J (2006) 5.79
Modernising medical careers, medical training application service, and the postgraduate medical education and training board: time for the emperors to don their clothes. Lancet (2007) 3.12
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 2.70
Skincare for newborns: guidelines and advice. RCM Midwives (2006) 2.01
Outcome parameters for trials in atrial fibrillation: executive summary. Eur Heart J (2007) 1.90
Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials. Eur Heart J (2005) 1.84
Dose-related effect of statins on atrial fibrillation after cardiac surgery. Ann Thorac Surg (2008) 1.57
[Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation]. G Ital Cardiol (Rome) (2009) 1.52
Impaired right ventricular systolic function demonstrated by reduced atrioventricular plane displacement in adults with Marfan syndrome. Eur J Echocardiogr (2008) 1.52
Early management of unstable angina and non-ST segment elevation myocardial infarction: summary of NICE guidance. BMJ (2010) 1.41
T-wave alternans and left ventricular wall thickness in predicting arrhythmic risk in patients with hypertrophic cardiomyopathy. Circ J (2010) 1.40
2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Rev Esp Cardiol (Engl Ed) (2016) 1.39
Stigma over smear tests. Community Pract (2005) 1.39
Atrial fibrillation--all change! Clin Med (2007) 1.38
Yearly zoledronic acid in postmenopausal osteoporosis. N Engl J Med (2007) 1.29
Current concepts in the pathogenesis of atrial fibrillation. Am Heart J (2008) 1.25
The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation. Am J Cardiol (2009) 1.21
Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches. Europace (2008) 1.19
An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality. Europace (2010) 1.08
Medical training in the UK: sleepwalking to disaster. Lancet (2007) 0.99
A phase I study of quisinostat (JNJ-26481585), an oral hydroxamate histone deacetylase inhibitor with evidence of target modulation and antitumor activity, in patients with advanced solid tumors. Clin Cancer Res (2013) 0.95
Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double-blind, placebo- and positive-controlled thorough QT study. Br J Clin Pharmacol (2012) 0.95
Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators. Europace (2009) 0.93
Comparison of the effects of levofloxacin on QT/QTc interval assessed in both healthy Japanese and Caucasian subjects (pages. Br J Clin Pharmacol (2012) 0.93
New insights into the initiation of atrial fibrillation: a detailed intraindividual and interindividual analysis of the spontaneous onset of atrial fibrillation using new diagnostic pacemaker features. Circulation (2006) 0.91
[ESH/ESC 2007 Guidelines for the management of arterial hypertension]. Rev Esp Cardiol (2007) 0.90
Driving and arrhythmias. BMJ (2002) 0.89
Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.89
Statins and polyunsaturated fatty acids for treatment of atrial fibrillation. Nat Clin Pract Cardiovasc Med (2008) 0.87
The impact of new and emerging clinical data on treatment strategies for atrial fibrillation. J Cardiovasc Electrophysiol (2010) 0.86
Successful treatment of heart failure with devices requires collaboration. Eur J Heart Fail (2008) 0.86
Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective survey. Clin Cardiol (2010) 0.85
The EHRA White Book. Europace (2012) 0.84
Current strategies in the management of atrial fibrillation. Ann Thorac Surg (2006) 0.83
Cardiotoxicity of fluoroquinolones. J Antimicrob Chemother (2002) 0.83
Utility of high and standard right precordial leads during ajmaline testing for the diagnosis of Brugada syndrome. Heart (2010) 0.83
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg (2016) 0.82
Effects of continuous and triggered atrial overdrive pacing on paroxysmal atrial fibrillation in pacemaker patients. Pacing Clin Electrophysiol (2008) 0.82
Early impairment of left ventricular long-axis systolic function demonstrated by reduced atrioventricular plane displacement in patients with Marfan syndrome. Eur J Echocardiogr (2008) 0.82
Biventricular and atrial diastolic function assessment using conventional echocardiography and tissue-Doppler imaging in adults with Marfan syndrome. Eur J Echocardiogr (2009) 0.80
Effect of aortic stiffness on left ventricular long-axis systolic function in adults with Marfan syndrome. Hellenic J Cardiol (2010) 0.80
Is there any hope for angiotensin-converting enzyme inhibitors in atrial fibrillation? Am Heart J (2007) 0.80
Impaired biventricular deformation in Marfan syndrome: a strain and strain rate study in adult unoperated patients. Echocardiography (2011) 0.80
Preoperative high-dose atorvastatin for prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. J Thorac Cardiovasc Surg (2010) 0.80
[Practice guidelines 2007 for the treatment of arterial hypertension]. G Ital Cardiol (Rome) (2007) 0.79
Update on atrial fibrillation: part II. Clin Cardiol (2008) 0.79
[Guidelines for cardiac pacing and cardiac resynchronization therapy]. Rev Port Cardiol (2008) 0.78
Assessment of aortic stiffness in marfan syndrome using two-dimensional and Doppler echocardiography. Echocardiography (2011) 0.78
Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators. Eur J Cardiovasc Nurs (2010) 0.78
Twenty-four-hour heart rate lowering with ivabradine in chronic heart failure: insights from the SHIFT Holter substudy. Eur J Heart Fail (2015) 0.77
Web-based virtual cardiac symposia: a new approach for worldwide professional medical education. Ann Noninvasive Electrocardiol (2007) 0.77
Assessment of carotid compliance using real time vascular ultrasound image analysis in Marfan syndrome. Echocardiography (2008) 0.76
Seek referral to a heart rhythm specialist for atrial fibrillation. BMJ (2012) 0.75
[Guidelines in cardiac pacing and resynchronization therapy]. Kardiol Pol (2007) 0.75
Cardiac risk of psychotropic drugs. Aust N Z J Psychiatry (2002) 0.75
Maternal mortality crisis in Chad. RCM Midwives (2005) 0.75
Getting a SureStart in life. Community Pract (2005) 0.75
Hepatitis C and a midwife's experiences. RCM Midwives (2005) 0.75
Breastfeeding: the need for a national strategy. RCM Midwives (2006) 0.75
The contributions of Paul Wood to clinical cardiology. Heart Lung Circ (2003) 0.75
Allergic reaction. Community Pract (2005) 0.75
Short patent lives jeopardize drug and patient safety. J Cardiovasc Pharmacol (2007) 0.75
Student midwives raise concerns. RCM Midwives (2006) 0.75
Bottle-feeding: report shows pressure on mothers. RCM Midwives (2005) 0.75
Early intervention and mental health. Community Pract (2005) 0.75
Quadricuspid aortic valve. Hellenic J Cardiol (2010) 0.75
The women the world forgot. RCM Midwives (2005) 0.75
Babies at risk from mothers' diabetes. RCM Midwives (2005) 0.75
Predictive characteristics of holter-based postinfarction risk stratifiers appear superior to electrophysiological testing. Pacing Clin Electrophysiol (2005) 0.75
[Guidelines on the management of stable angina pectoris: executive summary]. G Ital Cardiol (Rome) (2006) 0.75
Hospital Trust supports the RCM 'Campaign for normal birth'. RCM Midwives (2005) 0.75
Older people and wound management. Community Pract (2005) 0.75
Minister discusses the future of maternity services. RCM Midwives (2006) 0.75
Implantable cardioverter-defibrillator utilization. Europace (2011) 0.75
The cardiovascular continuum refined: A hypothesis. Blood Press (2010) 0.75
Excelling at inspections. Nurs Times (2003) 0.75
Midwives and complementary therapy. RCM Midwives (2006) 0.75
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology]. G Ital Cardiol (Rome) (2016) 0.75
New research on late abortion. RCM Midwives (2005) 0.75
The male midwife: one man's view on childbirth. RCM Midwives (2006) 0.75
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death]. Kardiol Pol (2015) 0.75